Healius Limited (HLS.AX)

1,1950 -0,0550 (-4,40%) Alla chiusura: 04:10PM AEST

Healius Limited

Liberty Place
Level 22 161 Castlereagh Street
Sydney, NSW 2000
Australia
61 2 9432 9400
https://www.healius.com.au

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 10.500

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Paul D. Anderson	MD, Group CFO, CEO & Director	220,62k	N/D	N/D
Mr. John McKechnie	Advisor	898,22k	855,47k	N/D
Dr. Jan Van Rooyen	Head & Group Executive of Healius Pathology	20,68k	N/D	N/D
Dr. Phil Lucas	Chief Executive of Lumus Imaging	N/D	N/D	N/D
Ian Mcphan	Chief Operating Officer of Healius Pathology	N/D	N/D	N/D
Sharon Ng	Head of Group FP&A	N/D	N/D	N/D
Ms. Mary Ellen Weaver AGIA	Company Secretary	N/D	N/D	N/D
Dr. John Houston	Advisor	1,07M	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in AUD.

Descrizione

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Governance aziendale

L'ISS Governance QualityScore di Healius Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.